Skip to main navigation Skip to search Skip to main content

Innovation mandate Spin-off: EVOZymes Development Platform

Project Details

Description

The main scientific goal of my 2-years project comprises conducting proof-of-concept in vivo studies of selected EVOZymes in appropriate IMD mouse models thereby defining the most suitable formulation, route of administration and dose ranging whereas the main valorisation goal comprises the development of a business plan for the spin-off company.
AcronymVLAIM5
StatusFinished
Effective start/end date1/08/2331/07/25

Keywords

  • evozymes

Flemish discipline codes in use since 2023

  • Pharmacology not elsewhere classified

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.